Twinlab
This article was originally published in The Tan Sheet
Executive Summary
Firm's common stock will be transferred to NASDAQ SmallCap Market effective Sept. 30, Hauppauge, N.Y.-based company announces Sept. 18. NASDAQ approved firm's application to move stock from National Market after setting Sept. 16 deadline for Twinlab to reply regarding its failure to meet market's $1 minimum listing price (1"The Tan Sheet" Aug. 5, 2002, p. 11)...
You may also be interested in...
Business & Financial News In Brief
Weider Nutrition brand divestiture: Optimum Nutrition subsidiary American Body Building picks up Weider's Science Foods, American Body Building brands in transaction that closed July 26. Deal affects 75-100 SKUs - primarily drinks and some bars - with total annual sales of slightly more than $20 mil. Transaction's total cost was not released, but final price includes roughly $5.7 mil. cash, assumption of approximately $250,000 mortgage on Walterborough, S.C. beverage manufacturing facility that was part of the deal. Acquisition gives Optimum Nutrition expanded line of beverages to complement current offerings of powders, capsules, bars. Weider says it will use net proceeds to reduce long-term debt, and transaction will negatively impact FY 2002 pre-tax financials by $8.7 mil.-$9.5 mil. Sale is part of Weider's effort to focus resources on Schiff Specialty Nutrition, Active Nutrition and Haleko business units...
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.